RayBiotech (China)

Recent papers from RayBiotech (China)

1. Assessing high-throughput surrogate assays for real-world HPV16- and HPV18-specific vaccine immune monitoring: a comparison of PBNA, cCLIA, and IgGFrontiers in Immunology · 2026
2. Advances in protein microarray–based proteomics for gastric cancer applications in biomarker discovery, molecular subtyping, and precision oncologyFrontiers in Oncology · 2026
3. Bioavailability of a novel anti-influenza agent, onradivir granules, in healthy Chinese adults: a first-in-human studyFrontiers in Pharmacology · 2026
4. Effects of a Dietary Supplement on Systemic Aging Related Biomarkers and Skin Aging Outcomes in Middle‐Aged Women: In Vitro and Clinical StudiesJournal of Cosmetic Dermatology · 2026
5. Proteomics of aging: biomarkers for physiological systems and diseasesFrontiers in Aging · 2026
6. A Novel Flow Cytometry Array for High Throughput Detection of SARS-CoV-2 Antibodies 2257921The Journal of Immunology · 2026
7. Strategies for Monitoring Serum Protein Degradation With an Antibody Array‐Based TechnologyJournal of Clinical Laboratory Analysis · 2026
8. Mechanisms of therapy resistance in the tumor microenvironment: Insights from antibody array–based cytokine profilingDrug Resistance Updates · 2026
9. Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subjectsBritish Journal of Clinical Pharmacology · 2026
10. A Novel Flow Cytometry Array for High Throughput Detection of SARS-CoV-2 AntibodiesVaccines · 2025
11. Combination detection of IgG- and IgA-related autoantibodies for the early diagnosis of gastric cancerCancer Biomarkers · 2025
12. Shaping the future of probiotics, live biotherapeutic products, and fecal microbiota transplantation: 30 scientific recommendations from the CHINAGUT ConferenceiMeta · 2025
13. Pharmacokinetics, safety, and tolerability of onradivir in participants with severe renal impairment and matched healthy control participantsAntimicrobial Agents and Chemotherapy · 2025
14. Unraveling tumor cell‑tumor microenvironment crosstalk through antibody array technologies (Review)International Journal of Oncology · 2025
15. Mechanisms of immune responses in juvenile Acanthopagrus latus to Aeromonas hydrophila infection revealed by multi-tissue transcriptomic analysisAquaculture Reports · 2025
16. Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participantsAntimicrobial Agents and Chemotherapy · 2025
17. Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancerWorld Journal of Hepatology · 2025
18. Single-dose tolerability and pharmacokinetics of leritrelvir in Chinese patients with hepatic impairment and healthy matched controlsAntimicrobial Agents and Chemotherapy · 2024
19. Constructions, Purifications and Applications of DNA-Antibody Conjugates: A ReviewACS Omega · 2024
20. Single‐Dose Tolerability and Pharmacokinetics of Onradivir in Chinese Patients with Hepatic Impairment and Healthy Matched ControlsThe Journal of Clinical Pharmacology · 2024